Home / Letter From The Editor / July 24, 2018

July 24, 2018

Jul 24, 2018
 

Way back in 2002 we had an article on in our newsletter on the newly discovered INGAP peptide (http://www.diabetesincontrol.com/issue-111-item-19-ingap-peptide-an-initiator-of-beta-cell-growth/ ) This peptide was thought to be able to regenerate beta cells, and early on it looked like a possible cure. Over the past 16 years we have had multiple features on the rise and fall of INGAP therapy. A couple of months ago one of our Pharm. D interns came to Steve and me to find out what ever happened to this research. Our Publisher, Steve Freed, caught up with Dr. Aaron Vinik at the AACE meeting in Boston to find out the latest.

Dave Joffe

 

Editor-in-chief